Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
New Avatec Plus 3-Nitro Combination-Use Approval Now Brings Turkey Growers the Only Ionophore-Based Coccidiosis Control with the Performance of 3-Nitro
King Pharmaceuticals, 06/24/09
Turkey growers can now capitalize on feeding an ionophore in combination with 3-Nitro, thanks to a new feed additive combination-use approval to medicate feed containing both Avatec and 3-Nitro. In late May, the U.S. Food and Drug Administration approved Alpharma Animal Health's application to combine the two products for turkeys. The approval permits use of Avatec at 68 to 113 grams of lasalocid per ton of feed in combination with 3-Nitro at 22.7 to 45.4 grams of roxarsone per ton of feed.
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/22/09
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists
Clinical Therapeutics, 10/15/09
Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials
Current Medical Research and Opinion, 10/27/09
Quality of Life Improvements Attributed to Combination Therapy with Oral and Topical Mesalazine in Mild-to-Moderately Active Ulcerative Colitis
Digestion, 10/15/09
Today in Drug/Product Alerts...keeping you current
Receive free subspecialty "5-minute updates" via email
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 11/02/09
Covidien Receives FDA Approval for Oral Transmucosal Fentanyl Citrate Product
Covidien, 11/05/09
Sponsor
Article Search
Sponsor


See Latest Articles


